Dermatology

Latest News

FDA Issues CRL for Lebrikizumab in Atopic Dermatitis
FDA Issues CRL for Lebrikizumab in Atopic Dermatitis

October 2nd 2023

At issue are findings from the agency’s inspection of a third-party manufacturing company. The FDA indicated there were no concerns about the safety or labeling of lebrikizumab.

Scripius Removes Dupixent from Formulary
Scripius Removes Dupixent from Formulary

September 7th 2023

 FDA Approves First Drug for Skin Infection from Pox Virus
FDA Approves First Drug for Skin Infection from Pox Virus

July 24th 2023

FDA Approves Pfizer’s Alopecia Drug
FDA Approves Pfizer’s Alopecia Drug

June 26th 2023

NDA Sets Goal Date for Skin Infection Gel
NDA Sets Goal Date for Skin Infection Gel

March 7th 2023

© 2023 MJH Life Sciences

All rights reserved.